Is This Medication Safe for My Child? How to Discuss Safety of Commonly Used Medications With Parents

J Allergy Clin Immunol Pract. 2022 Dec;10(12):3064-3072. doi: 10.1016/j.jaip.2022.07.032. Epub 2022 Aug 10.

Abstract

All drugs have potential side effects, but thoughtful use can maximize benefits while minimizing risks. Children should not be considered just small adults regarding drug safety because their growth and development are discordant with their ability to sense and self-report drug side effects. Detecting side effects requires vigilance and education from prescribers to parents, who are tasked with monitoring their child over time. A drug's safety profile is published in the package label after pivotal trials are conducted in relatively small and sometimes narrow segments of the population during the U.S. Food and Drug Administration approval process. Drug safety profiles can change as data from postmarketing reports and long-term monitoring during phase IV trials emerge. As such, prescribers are obligated to maintain current understanding of any changes to drug labels. Discussing potential side effects, monitoring, and when to report concerns can be a time-consuming process during patient encounters. This review offers current information regarding potential side effects of some of the most commonly used medications for allergic conditions, asthma, and atopic dermatitis. This information and discussion will hopefully assist clinicians in their conversations with parents, including advice surrounding prescribing medication to minimize adverse effects, parental monitoring, and documentation.

Keywords: Allergic rhinitis; Asthma; Atopic Dermatitis; Calcineurin inhibitors; Children; Corticosteroids; Long-acting beta agonists; Montelukast; Safety.

Publication types

  • Review

MeSH terms

  • Adult
  • Asthma* / drug therapy
  • Child
  • Dermatitis, Atopic* / drug therapy
  • Humans
  • United States
  • United States Food and Drug Administration